For optimal viewing of the AACI Update click here.
News from the Association of American Cancer InstitutesFebruary 2012
The AACI is dedicated to promoting the common interests of the nation’s leading academic cancer centers that are focused on the eradication of cancer through a comprehensive and multidisciplinary program of cancer research, treatment, patient care, prevention, education, and community outreach.
AACI Update is an e-newsletter for the cancer center directors and key contacts at AACI member institutions and individuals interested in the cancer center-related activities of AACI. AACI Update reports on the progress of AACI initiatives and other AACI endeavors that benefit the cancer community and highlights important news and events at AACI member institutions.

AACI encourages member institutions to submit cancer center highlights to AACI Update. News briefs are linked to complete stories posted on individual cancer center websites. Please e-mail materials to AACI reserves the right to decide whether or not materials are appropriate for inclusion.

To subscribe to AACI Update, please send an e-mail to with your name, title, address, telephone and fax numbers asking to be added to the AACI’s distribution list.

To unsubscribe from AACI Update, please send an e-mail to with your name, title, and unsubscribe in the subject line to be removed from AACI’s distribution list.

Mailing address:
3708 Fifth Avenue
Medical Arts Building, Suite 503
Pittsburgh, PA 15213


Rep. Israel Backs Resolution Recognizing National Cancer Act
U.S. Representative Steve Israel (D-NY) is spearheading the introduction of a resolution recognizing the 40th anniversary of the National Cancer Act of 1971. The resolution highlights the more than 12 million survivors of cancer who are alive today because of the commitment of the United States to cancer research and advances in cancer prevention, detection, diagnosis, and treatment. more...

AACI Urges CMS to Ensure Clinical Trials Access
AACI recently joined the American Association for Cancer Research, the American Society of Clinical Oncology, and other cancer research advocates in submitting recommendations to the Centers for Medicare and Medicaid Services on the Affordable Care Act provision requiring health plans to cover routine patient costs associated with clinical trial participation. more...

Save the Date for Capitol Hill Visit
AACI has scheduled its annual Hill Day for Thursday, May 17, 2012, in Washington, DC. The event will showcase for members of Congress the work of the nation’s cancer centers and how federal investment in research sustains progress in the fight against cancer. The American Association for Cancer Research, American Society of Clinical Oncology, and Friends of Cancer Research are co-sponsoring the event with AACI. more...

2011 AACI Report Now Online
An up-to-date overview of AACI’s programs and initiatives is now available online in our 2011 Report. The publication highlights the Association’s progress toward achieving its strategic goals of promoting broad recognition of the cancer center network, facilitating interaction among centers, and fostering collaboration and communication with local communities and other cancer organizations. more...
News from the Centers
Awards & Honors
AACI Director Honored with Japan Prize
Knight Cancer Institute
Oregon Health & Science University Knight Cancer Institute Director Brian J. Druker, MD, was awarded the 2012 Japan Prize in Healthcare and Medical Technology for his pioneering role in targeted cancer drugs. He is sharing the award with Janet Davison Rowley, MD, of the University of Chicago, and Nicholas B. Lydon, PhD, formerly with Novartis. more...
Pitha-Rowe Elected to AAAS
Sidney Kimmel Comprehensive Cancer Center
Six Johns Hopkins researchers have been elected by their peers as fellows of the American Association for the Advancement of Science, including Paula Pitha-Rowe, PhD, of the Sidney Kimmel Comprehensive Cancer Center. more...
Rossi Elected AAAS Fellow
City of Hope National Medical Center and Beckman Research Institute
John J. Rossi, PhD, has been elected a fellow of the American Association for the Advancement of Science. The association, which publishes the journal Science, is among the largest scientific organizations in the world. more...
Robbins Named First Simmons Cancer Institute Endowed Chair
SimmonsCooper Cancer Institute
Dr. K. Thomas Robbins, professor of otolaryngology at Southern Illinois University School of Medicine and director of Simmons Cancer Institute, has been named the recipient of the Simmons Cancer Institute Endowed Chair of Excellence in Oncology at SIU School of Medicine in Springfield. Robbins has been selected as the first to hold the chair because of his more than 30-year career in the field of head and neck surgical oncology and the international recognition he has earned for his work. more...
Huntsman Awarded Top Honors as Cancer Imaging Facility
Huntsman Cancer Institute
Huntsman Cancer Institute at the University of Utah has been named by the National Cancer Institute as a Center for Quantitative Imaging Excellence. more...
Obama Names Researcher to Serve on the President’s Cancer Panel
Jonsson Comprehensive Cancer Center, UCLA
Owen Witte, MD, founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and a renowned cancer researcher, has been selected by President Barack Obama to serve on the President’s Cancer Panel, which monitors the development and execution of the National Cancer Program. more...
UNM Cancer Center Member Appointed to Scientific Advisory Council
University of New Mexico Cancer Center
Maggie Werner-Washburne, PhD, has been appointed to the advisory council of the National Institutes of Health’s National Institute of General Medical Sciences, which supports research that increases understanding of life processes and lays the foundation for advances in disease diagnosis, treatment and prevention. more...
Grants & Gifts
MSK Receives $50 Million in Honor of Josie Robertson
Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center has joined with The Robertson Foundation to undertake two high-profile initiatives in honor of Josephine “Josie” Robertson. Helping to make the tribute a reality is a $50 million commitment from The Robertson Foundation. more...
LoRusso Co-Leads Stand Up To Cancer Melanoma Research Alliance Dream Team
Barbara Ann Karmanos Cancer Institute
Patricia M. LoRusso, DO, of the Barbara Ann Karmanos Cancer Institute; and Jeffrey M. Trent, PhD, of the Translational Genomics Research Institute in Phoenix, Arizona; have been selected to lead a Stand Up To Cancer - Melanoma Research Alliance Dream Team. more...
New Outpatient Building to Expand Cancer Care At USC
USC/Norris Comprehensive Cancer Center
The University of Southern California has announced an expansion of cancer care facilities made possible by a $15 million donation from the Kenneth T. and Eileen L. Norris Foundation. The gift will support construction on the USC Health Sciences campus of a new outpatient clinic building that will be named the Norris Healthcare Consultation Center. more...
Cellular-Imaging Center Receives Over $8 Million
Sidney Kimmel Comprehensive Cancer Center
A team of cancer imaging experts at Johns Hopkins has embarked on a five-year research initiative to speed development of early diagnostic tests and new treatments for breast, prostate and other common cancers. more...
Vanderbilt Team Chosen to Participate in Proteomic Cancer Research Consortium
Vanderbilt-Ingram Cancer Center
A team of Vanderbilt-Ingram Cancer Center scientists, led by Daniel C. Liebler, PhD, has been selected to participate in the Clinical Proteomic Tumor Analysis Consortium, a multi-institution cancer research program created by the National Cancer Institute. more...
Grant Focuses Genome Sequencing for Children with Cancer
The Dan L. Duncan Cancer Center
A groundbreaking study that investigates how genome sequencing can be incorporated into the clinical care of children with cancer will launch at Baylor College of Medicine and Texas Children’s Cancer Center with support from a $6 million grant from the National Human Genome Research Institute and the National Cancer Institute. more...
Leadership Transitions
Prominent Japanese Geneticist Joins UChicago Faculty
University of Chicago Comprehensive Cancer Center
Yusuke Nakamura, MD, PhD, secretary general of the Japanese Government’s Office of Medical Innovation and a professor of molecular medicine at Tokyo University’s Human Genome Center, will join the faculty at The University of Chicago in April. more...
Neuroendocrine and Neuro-Oncology Specialists Join Markey
Lucille P. Markey Cancer Center
Two new specialists have joined the University of Kentucky Markey Cancer Center. Dr. Lowell Anthony, who specializes in the treatment of neuroendocrine tumors and gastrointestinal cancers, will lead and develop the Neuroendocrine Clinical Oncology Program. Dr. John Villano, specializing in brain cancer treatment, will develop UK’s Clinical Neuro-Oncology Research Program, serving as its director. more...
Research Highlights
Study: Two Drugs Used for Cancer Treatments Increase Breast Cancer Stem Cells
University of Michigan Comprehensive Cancer Center
Cancer treatments designed to block the growth of blood vessels were found to increase the number of cancer stem cells in breast tumors in mice, according to a new study of the University of Michigan Comprehensive Cancer Center, led by Max S. Wicha, MD, director of the center. more...
Researchers Uncover New Mechanism in Multiple Myeloma Cells
Massey Cancer Center
Research by Steven Grant, MD, and colleagues at Virginia Commonwealth University Massey Cancer Center have discovered a mechanism in multiple myeloma cells that plays a critical role in the cells’ ability to resist treatments involving a class of drugs known as histone deacetylase inhibitors. more...
Faulty Proteins May Be Significant in Identifying New Ovarian Cancer Treatments
Knight Cancer Institute
A group of defective proteins suspected in causing malfunction in the body’s ability to repair its own DNA could help prove the effectiveness of a new class of drugs in treating many ovarian cancer patients, according to an Oregon Health & Science University Knight Cancer Institute study, led by said Tanja Pejovic, MD, PhD. more...
Vanderbilt Study Finds Prostate Size May Help Predict Cancer Severity
Vanderbilt-Ingram Cancer Center
The size of a man’s prostate gland may help predict the severity of cancer, with a smaller prostate being more likely to harbor serious disease. This finding by Vanderbilt-Ingram Cancer Center researchers was published in the December issue of the Journal of Urology. Daniel Barocas, MD, MPH, was senior author. more...
Moffitt Researchers Find New, Noninvasive Way To Identify Lymph Node Metastasis
Moffitt Cancer Center
Using two cell surface markers found to be highly expressed in breast cancer lymph node metastases, researchers at Moffitt Cancer Center, working with colleagues at other institutions, have developed targeted, fluorescent molecular imaging probes that can non-invasively detect breast cancer lymph node metastases. more...
Adding Chemotherapy to Radiation Doubles Survival Time for Some Brain Tumor Patients
Winship Cancer Institute
The addition of chemotherapy to radiation therapy nearly doubled median survival time for patients with anaplastic oligodendroglioma. The finding is from a phase III trial in which patients were followed for a median of 11 years. Walter J. Curran, Jr., MD, executive director of Winship Cancer Institute of Emory University, was a senior author of the study. more...
Novel Drug Shown to Slow Breast Cancer Growth Available in Markey Clinical Trial
Lucille P. Markey Cancer Center
A new drug that could slow breast cancer metastasis by several months is currently available in a clinical trial at the University of Kentucky Markey Cancer Center. more...
Nanoparticles Refined for More Accurate Delivery of Cancer Drugs
UC Davis Cancer Center
A new class of nanoparticles, synthesized by a UC Davis research team to prevent premature drug release, holds promise for greater accuracy and effectiveness in delivering cancer drugs to tumors. more...
Selective Targeting and Blocking of MicroRNA to Treat Liver Cancer is Possible
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute
A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The findings might offer a new therapy for this malignancy, which kills an estimated 549,000 people worldwide annually. more...
Study Pinpoints and Plugs Mechanism of AML Cancer Cell Escape
University of Colorado Comprehensive Cancer Center
A study published in the journal Leukemia identifies a mechanism that acute myeloid leukemia (AML) cells use to evade chemotherapy – and details how to close this escape route. Christopher Porter, MD, was lead author. more...
Study Shows Cell Signaling Key to Stopping Brain Cancer Cell Growth, Migration
University of Colorado Comprehensive Cancer Center
New research at the University of Colorado Cancer Center has found that cells signal themselves to survive, grow, reproduce, and migrate. Amy Keating, MD, was senior author of the study. Two years ago, researchers at the CU Cancer Center showed that turning off a family of signals made brain cancer cells less robust – it sensitized these previously resistant cells to chemotherapy. more...
Research Shows Mass Prostate Cancer Screenings Don’t Reduce Death
Siteman Cancer Center, Barnes Jewish Hospital at Washington University School of Medicine
There’s new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington University School of Medicine in St. Louis. Gerald Andriole, MD, was lead author of the study. more...
Researchers Discover Hormonal Signaling Process Is Linked to Obesity and Cancer
USC/Norris Comprehensive Cancer Center
Researchers at the Keck School of Medicine of the University of Southern California have discovered that a signaling process between a hormone receptor produced by the brain and a hormone produced by fat tissue is a characteristic feature of a variety of tumor-initiating stem cells, providing a key link between obesity and the development of cancer. Keigo Machida, PhD, was lead author of the study. more...
Researchers Discover More Accurate Delivery of Cancer Drugs
UC Davis Cancer Center
A new class of nanoparticles, synthesized by a UC Davis research team to prevent premature drug release, holds promise for greater accuracy and effectiveness in delivering cancer drugs to tumors. The work was published online in Angewandte Chemie, a leading international chemistry journal. more...
Mechanism of Lung-Cancer Drug Resistance Revealed in Study
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute
New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs. Carlo M. Croce, MD, was principal investigator. more...
Dana-Farber Institute Researchers Isolate Messenger Protein Linking Exercise to Health Benefits
Dana-Farber Cancer Institute
A team led by Bruce Spiegelman, PhD, at Dana-Farber Cancer Institute has isolated a natural hormone from muscle cells that triggers some of the key health benefits of exercise. They say the protein, which serves as a chemical messenger, is a highly promising candidate for development as a novel treatment for diabetes, obesity and perhaps other disorders, including cancer. more...
Researchers Find Key Genetic Error in Family of Blood Cancers
Siteman Cancer Center, Barnes Jewish Hospital at Washington University School of Medicine
Scientists have uncovered a critical genetic mutation in some patients with myelodysplastic syndromes — a group of blood cancers that can progress to a fatal form of leukemia. A research team at Washington University School of Medicine in St. Louis also found evidence that patients with the mutation are more likely to develop acute leukemia. more...
Researchers Use Homing Peptide to Shrink Tumors
Sanford-Burnham Medical Research Institute
A team led by Michiko Fukuda, PhD, coupled a cancer drug to a small protein called IF7, which is specifically attracted to the blood vessels that feed tumors. When administered in a mouse model of human colon cancer, IF7 carried the drug directly to tumors, where it suppressed growth at low dosages and with no apparent side effects. more...
Study: Patients Get Half of Recommended Preventive Services at Annual Check-ups
Massey Cancer Center
More than 20 percent of U.S. adults receive periodic health examinations each year, yet new research shows that patients who have an annual routine visit to their doctor may not receive recommended preventive screening tests and counseling services that could benefit their health. more...
Thought Leadership Paper on Drug Repurposing Published
University of New Mexico Cancer Center
A paper by Tudor Oprea, MD, PhD, and colleagues at University of New Mexico (UNM) Cancer Center researchers in the December issue of Drug Discovery Today: Therapeutic Strategies details 11 drug repurposing projects at UNM, the majority of them relevant to cancer treatment. more...
Surgeons Co-author Study on Breast Cancer Treatment Decision Making
UNC Lineberger Comprehensive Cancer Center
UNC scientists participated in a four-institution study involving 440 women with early-stage breast cancer and found that breast cancer survivors had limited knowledge about their surgical options, including an understanding of something as important as the risk of recurrence. Their findings are reported in the January 2012 issue of the Journal of the American College of Surgeons. more...
IU Researcher Tapped for Top Cancer Advance
Indiana University Melvin and Bren Simon Cancer Center
Bryan Schneider, MD, associate professor of medicine at Indiana University School of Medicine, and colleagues identified a genetic biomarker that causes neuropathy among some breast cancer patients using a class of chemotherapy drugs called taxanes. That research is featured in 2011 Clinical Cancer Advances: ASCO’s Annual Report on Progress Against Cancer. more...
Clinical Trial Shows Taking Smoking Cessation Medication Before Quitting May Make Staying Tobacco-Free Easier
Roswell Park Cancer Institute
Smokers planning to kick the habit may have more success if they begin using a cessation medication several weeks before they actually try to quit. Those are the results of a clinical trial conducted by researchers at the University at Buffalo, Roswell Park Cancer Institute and other institutions, published recently in Clinical Pharmacology and Therapeutics. Larry W. Hawk, Jr., PhD, was lead author. more...
Researchers Discover Patterns of Genes Associated with Timing of Breast Cancer Recurrences
Lombardi Comprehensive Cancer Center at Georgetown University
An international research team led by Georgetown Lombardi Comprehensive Cancer Center has found biological differences in hormone-receptor positive breast cancer that are linked to the timing of recurrence despite endocrine therapy. more...
Study Finds Preventive Use of Blood Thinners by Cancer Patients Could Save Lives and Cut Costs
University of Pittsburgh Cancer Institute
Preventive use of blood thinners, or anticoagulants, in people receiving outpatient treatment for cancer could prevent the development of blood clots and improve their quality of life, according to a study led by Margaret Ragni, MD, PhD. more...
Study: Diet Rich in Slowly Digested Carbs Cuts Inflammation In Overweight Adults
Fred Hutchinson Cancer Research Center
Among overweight and obese adults, a diet rich in slowly digested carbohydrates, such as whole grains, legumes and other high-fiber foods, significantly reduces markers of inflammation associated with chronic disease, according to a new study by Fred Hutchinson Cancer Research Center. more...
Lombardi Leads Discovery Expected to Significantly Change Biomedical Research
Lombardi Comprehensive Cancer Center at Georgetown University
In a major step that could revolutionize biomedical research, scientists have discovered a way to keep normal cells as well as tumor cells taken from an individual cancer patient alive in the laboratory — which previously had not been possible. more...
Baylor Researchers Develop New Cancer Treatment Direction
The Dan L. Duncan Cancer Center
Just as people’s bodies and minds can become addicted to substances such as drugs, caffeine, alcohol, their cancers can become addicted to certain genes that ensure their continued growth and dominance. Researchers at Baylor College of Medicine and Harvard Medical School have developed ways to exploit the addictions of cancers to kill them without harming normal tissues. A report on their work appears online in the journal Science. more...
System Transformation to Improve Cancer Care
Indiana University Melvin and Bren Simon Cancer Center
In “Quality Measurement and System Change of Cancer Care Delivery,” published in the Regenstrief Conference supplement to the December 2011 issue of the journal Medical Care, investigators from the Regenstrief Institute and the Indiana University School of Medicine explore current cancer care quality measurement and discuss new ways to empower patients and promote system transformation to improve quality of care. more...
Study Will Examine Economics of Colorectal Cancer Screening
UNC Lineberger Comprehensive Cancer Center
A new study at UNC Chapel Hill will examine what complex and conjoined behavioral factors influence low income people to pursue colorectal cancer screening and what strategies could increase screening rates in disadvantaged communities. more...
Roswell Park Launches Landmark Vaccine Trial
Roswell Park Cancer Institute
The Center for Immunotherapy at Roswell Park Cancer Institute (RPCI) has launched a phase I clinical research study of a dendritic cell vaccine designed to both eradicate cancer cells and prevent disease relapse. The new NY-ESO-1 dendritic cell vaccine is expected to show great promise in patients with bladder, brain, breast, esophageal, gastrointestinal, hepatocellular, kidney, lung, melanoma, ovarian, prostate, sarcoma and uterine tumors. more...
Study Finds Gender Differences in Liver Cancer Risk
Abramson Cancer Center of the University of Pennsylvania
Men are four times more likely to develop liver cancer compared to women, a difference attributed to the sex hormones androgen and estrogen. Although this gender difference has been known for a long time, the molecular mechanisms by which estrogens prevent -- and androgens promote -- liver cancer remain unclear. more...
Penn Researchers Use Cell Tracking to See Metastasis of Pancreatic Cancer in Action
Abramson Cancer Center of the University of Pennsylvania
Ben Stanger, MD, PhD, assistant professor of Medicine in the Division of Gastroenterology at the Perelman School of Medicine, University of Pennsylvania, and Andrew Rhim, MD, a Gastroenterology Fellow in the Stanger lab, discovered that pancreatic cancer cells in an animal model begin to spread before clinically obvious tumor tissue is detected. more...
Dana-Farber Researchers Link "Pulverized" Chromosomes to Cancer
Dana-Farber Cancer Institute
In a paper published in the journal Nature, Dana-Farber Cancer Institute researchers have mapped out a mechanism by which micronuclei could potentially disrupt the chromosomes within them and produce cancer-causing gene mutations. David Pellman, MD, was the study’s senior author. more...
Michigan Research Shows Potential New Approach for Treating Graft-vs-Host Disease
University of Michigan Comprehensive Cancer Center
Researchers from the University of Michigan Comprehensive Cancer Center tested alpha-1-antitrypsin in mice that received allogeneic bone marrow transplants, finding that the drug significantly reduced mortality from graft-vs.-host disease compared to control mice. Pavan Reddy, MD, was senior study author. more...
Researchers Reveal Mechanism by Which Melanoma Drug Accelerates Secondary Skin Cancers
Jonsson Comprehensive Cancer Center, UCLA
UCLA Jonsson Comprehensive Cancer Center researchers working with investigators from the Institute of Cancer Research in London, Roche and Plexxikon, have elucidated the mechanism by which vemurafenib excels at fighting melanoma but also allows for the development of skin squamous cell carcinomas. Antoni Ribas, MS, was co-senior author of the paper. more...
Northwestern Studies Identify Promising Genes and Molecules to Use Against Diseases
The Robert H. Lurie Comprehensive Cancer Center
Two related studies from Northwestern University offer new strategies for tackling the challenges of preventing and treating diseases of protein folding, such as Alzheimer’s, Parkinson’s and Huntington’s diseases, amyotrophic lateral sclerosis (ALS), cancer, cystic fibrosis and type 2 diabetes. more...
UAB Researchers Find New Way to Control Tumor Growth
UAB Comprehensive Cancer Center
New evidence by University of Alabama at Birmingham researchers that specific electromagnetic fields can safely block the proliferation of cancer cells and tumor growth may help refine a new, targeted therapy without any collateral damage. Boris Pasche, MD, PhD, is director of the UAB Division of Hematology and Oncology. more...
UC San Diego Researchers Review Cessation Studies and Call for Policy Change
Rebecca and John Moores UCSD Cancer Center
In the 2012 edition of the Annual Review of Public Health, University of California, San Diego School of Medicine researchers have reviewed the past 20 years of smoking cessation. While this time period has seen improvements in pharmaceutical medications to aid cessation, and free telephone cessation coaching has become available in every state, recent trends are troubling to tobacco control researchers. more...
Case Publishes Study on Novel Treatment for Skin Lymphoma
Case Comprehensive Cancer Center, Case Western Reserve University
Promising findings on a novel combination treatment approach for a chronic type of skin lymphoma have been published in JAMA’s Archives of Dermatology by clinical researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine. more...
Researchers Solve the Structure of a Promising DNA-Targeting Molecule for Gene Correction, Therapy
Fred Hutchinson Cancer Research Center
Researchers at Fred Hutchinson Cancer Research Center have solved the three-dimensional structure of a newly discovered type of gene-targeting protein that has shown to be useful as a DNA-targeting molecule for gene correction, gene therapy and gene modification. The findings are published in Science Express. more...
Study Identifies a Key Molecular Switch for Telomere Extension by Telomerase
University of Illinois at Chicago Cancer Center
Researchers at the University of Illinois at Chicago College of Medicine describe for the first time a key target of DNA damage checkpoint enzymes that must be chemically modified to enable stable maintenance of chromosome ends by telomerase, an enzyme thought to play a key role in cancer and aging. more...
Study Finds Potential Key To Immune Suppression In Cancer
Moffitt Cancer Center
In a study investigating immune response in cancer, researchers from Moffitt Cancer Center and the University of South Florida have found that interaction between the immune system’s antigen-specific CD4 T cells and myeloid-derived suppressor cells--cells that play a major role in cancer-related immune suppression--dramatically change the nature of MDSC-mediated suppression. more...
Direct Injection Vaccine for Pancreas Cancer Associated with Stable Disease
The Cancer Institute of New Jersey
A series of vaccine injections given directly into a pancreatic cancer tumor is shown to be associated with stable disease in patients who are not candidates for surgery. Early results of a clinical trial being conducted at The Cancer Institute of New Jersey were presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics meeting in San Francisco. more...
Other News
Temple University and Fox Chase Sign Affiliation Agreement
Fox Chase Cancer Center
Temple University Health System and Fox Chase Cancer Center have signed an affiliation agreement that moves both institutions closer to bringing Fox Chase into the Temple family – marking a major milestone for two celebrated Philadelphia institutions that will enhance cancer research and patient care in the region. more...
Nevada Cancer Institute Inks Sales Agreement with UC San Diego
Nevada Cancer Institute
Nevada Cancer Institute has entered into an agreement to sell its state-of the-art outpatient cancer treatment facility, its operations, and certain personal property to the UC San Diego Health System. more...
Arizona Enters Affiliation Agreement
Arizona Cancer Center
The University of Arizona Cancer Center and St. Joseph’s Hospital and Medical Center/CHW have entered into an agreement to form an innovative collaboration in Phoenix. more...
New Optics Technology Featured in "Breakthrough in Early Cancer Detection"
The Robert H. Lurie Comprehensive Cancer Center
“Early detection is probably the only way for us to win the war against cancer,” says Northwestern University’s Vadim Backman in a Science Nation video featured by the National Science Foundation. Backman has been developing a suite of novel optics technologies with the goal of making early detection cheaper, more accurate and less invasive for an array of cancers. more...
Wistar Launches New Research Program
The Wistar Institute
The Wistar Institute Cancer Center has been restructured into three programs that build on Wistar’s scientific strengths and support research in areas with the most promise for yielding near-term breakthroughs. José Conejo-Garcia, MD, PhD, a tumor immunologist who studies ovarian cancer, has been appointed leader of the new Tumor Microenvironment and Metastasis Program, with Meenhard Herlyn, DVM, PhD, as co-leader. more...
Montefiore and Albert Einstein Establish Office of Clinical Trials
Comprehensive Cancer Center Albert Einstein College of Medicine
Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University have established an Office of Clinical Trials to bring new therapies more rapidly to patients through the facilitation of efficient, compliant and timely conduct and management of clinical studies. more...
Sanford-Burnham and Pfizer Collaborate
Sanford-Burnham Medical Research Institute
Sanford-Burnham Medical Research Institute is the latest research organization to partner with Pfizer, Inc. as part of Pfizer’s commitment to transforming research and development through a focus on translational medicine. more...
Job Opportunities
Director - Central Protocol & Data Monitoring,
Clinical Trials Administration  
St. Jude Childrens Research Hospital


Director, Cancer Institute Administration  
Samuel Oschin Comprehensive Cancer Center Institute


CRA Manager – Oncology Clinical Protocol Office  
University of North Carolina
Lineberger Comprehensive Cancer Center


Associate or Full Professor
Cancer Epidemiologist  
The George Washington University
School of Public Health and Health Services and Cancer Institute


Director of Biostatistics and Bioinformatics (DBB)  
Duke Cancer Institute


CRA Manager – Oncology Clinical Protocol Office  
University of North Carolina
Lineberger Comprehensive Cancer Center


Faculty Position in Cancer Research – Oxidative stress/DNA repair  
The University of Kentucky Markey Cancer Center


Faculty Position in Cancer Research – Lung Cancer  
The University of Kentucky Markey Cancer Center


Meeting Announcements

2012 CCAF Spring Meeting

2012 CCAF Spring Meeting
March 4 – 6, 2012
Denver, Colorado
For more information visit:

Second Symposium on Translational Genomics

National Cancer Institute Symposium on Integrative Cancer Biology and Genomics
March 15-16, 2012
National Institutes of Health, Bethesda, MD

The field of translational genomics is rapidly progressing, yet the systematic application of current knowledge to improve patient care remains a formidable challenge. This symposium will provide a dedicated forum for the advancement, implementation and exchange of information on noncoding RNAs, next generation sequencing, and epigenomics and genetic variation for translation into clinical practice with the ultimate goal to improve the health of patients with cancer.

The latest information about the symposium can be found on the website at

2012 AACI/CCAF Annual Meeting

Save the Date!
2012 AACI/CCAF Annual Meeting
October 14-16, 2012
The Westin Chicago River North
Chicago, IL